Search results
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Healthcare Professionals Novartis works closely with healthcare professionals around the world to support their treatment of patients and collaborate on unmet needs.
Novartis Pharmaceuticals Canada has introduced new medicines that have had an important impact on patients suffering from a wide variety of major illnesses.
Product Portfolio. As a science-based and patient-oriented healthcare company, we strive to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis is focused on three divisions with global scale and innovation power – pharmaceuticals, eye care and generic medicines.
Novartis in Society integrated Report 2023. This report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.
The Novartis Singapore site is their first biologics production facility in Asia and one of the largest biologics manufacturing investments in Singapore. It is aimed to launch and produce innovative biologics medicines to transform patients’ lives.
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Healthcare Professionals Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.
Novartis commits to addressing racial disparities in breast cancer screening, treatment and care. Novartis today announced the launch of More Than Just Words, a multiyear commitment to promote health equity in breast cancer care, where there is significant unmet need. Black women under the age of 35 are diagnosed with breast cancer at twice the ...
